Inhibition of neointimal hyperplasia after balloon injury by cis-element ‘decoy’ of early growth response gene-1 in hypercholesterolemic rabbits

被引：0
作者：
K Ohtani
K Egashira
M Usui
M Ishibashi
K-I Hiasa
Q Zhao
M Aoki
Y Kaneda
R Morishita
A Takeshita
机构：
[1] Graduate School of Medical Sciences,Department of Cardiovascular Medicine
[2] Kyushu University,Division of Gene Therapy Science
[3] Osaka University Medical School,undefined
来源：
Gene Therapy | 2004年 / 11卷
关键词：
neointimal hyperplasia; inflammation; growth factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Early growth response factor-1 (Egr-1) is a transcription factor that is rapidly activated after vascular injury and thus might contribute to vascular proliferation and inflammation. We hypothesized that Egr-1 might therefore be a therapeutic target against restenosis. Hypercholesterolemic rabbits were intraluminally administered synthetic DNA as a ‘decoy’ against Egr-1 immediately after carotid artery balloon injury. Efficient transfection was confirmed by the delivery of a fluorescence-labeled decoy. Gel mobility-shift assay showed increased Egr-1 activity after balloon injury and its prevention by Egr-1 decoy transfection in vivo. Egr-1 decoy transfection attenuated early inflammation and proliferation and later neointimal hyperplasia. In addition, Egr-1 decoy transfection reduced gene expression and protein production of Egr-1-dependent genes such as platelet-derived growth factor-B, transforming growth factor-β1, and monocyte chemoattractant protein-1. The Egr-1 pathway has an essential role in the pathogenesis of neointimal hyperplasia after balloon injury in hypercholesterolemic rabbits. This decoy strategy is a potential practical form of therapy for human restenosis.
引用
收藏
页码：126 / 132
页数：6
相关论文
共 38 条
[1]  
Ross R(1999)Atherosclerosis – an inflammatory disease N Engl J Med 340 115-126
[2]  
Lusis AJ(2000)Atherosclerosis Nature 407 233-241
[3]  
Glass CK(2001)Atherosclerosis. The road ahead Cell 104 503-516
[4]  
Witztum JL(1997)Restenosis revisited – new targets, new therapies N Engl J Med 337 418-419
[5]  
Libby P(1998)Frontiers in interventional cardiology Circulation 98 1802-1820
[6]  
Ganz P(2002)A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 1773-1780
[7]  
Topol EJ(2001)Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up Circulation 104 2007-2011
[8]  
Serruys PW(1997)Inducible expression of Egr-1-dependent genes. A paradigm of transcriptional activation in vascular endothelium Circ Res 81 457-461
[9]  
Morice MC(1996)Egr-1-induced endothelial gene expression: a common theme in vascular injury Science 271 1427-1431
[10]  
Sousa JE(2000)Catalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function J Clin Invest 106 1189-1195
1234